Bayesian Benefit-Risk Assessment with Dependent Outcomes via Latent Factor Models

Konstantinos Vamvourellis, Konstantinos Kalogeropoulos, Lawrence Phillips

Approving and assessing new drugs is complex because multiple criteria must be considered simultaneously. A common approach is benefit-risk analysis, often conducted within a Bayes…